Live Breaking News & Updates on Howard Capital Management Inc|Page 1

Stay updated with breaking news from Howard capital management inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cantor Fitzgerald Reaffirms "Overweight" Rating for Taysha Gene Therapies (NASDAQ:TSHA)

Cantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $7.00 target price on the stock. A number of other equities research analysts have also recently issued reports on the stock. Piper Sandler began coverage on […] ....

Piper Sandler , China Universal Asset Management Co , Howard Capital Management Inc , Lee Financial Co , Canaccord Genuity Group , Victory Capital Management Inc , Dynamic Technology Lab Private Ltd , Taysha Gene Therapies Company Profile , Taysha Gene Therapies Inc , Cantor Fitzgerald , Needham Company , Taysha Gene Therapies , Free Report , Genuity Group , Gene Therapies Stock Down , Gene Therapies , Get Free Report , Capital Management , Technology Lab Private Ltd , Universal Asset Management , Taysha Gene Therapies Daily ,

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $7.00 Consensus Target Price from Analysts

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have covered the stock […] ....

Canaccord Genuity Group , Jefferies Financial Group , Taysha Gene Therapies Inc , Victory Capital Management Inc , Kovitz Investment Group Partners , China Universal Asset Management Co , Howard Capital Management Inc , Cantor Fitzgerald , Commonwealth Equity Services , Needham Company , Taysha Gene Therapies Company Profile , Taysha Gene Therapies , Get Free Report , Financial Group , Equity Services , Investment Group Partners , Capital Management , Universal Asset Management , Victory Capital Management , Gene Therapies , Get Free , Taysha Gene Therapies Daily ,

Wealthcare Advisory Partners LLC Buys 2,350 Shares of Franklin U.S. Large Cap Multifactor Index ETF (BATS:FLQL)

Wealthcare Advisory Partners LLC Buys 2,350 Shares of Franklin U.S. Large Cap Multifactor Index ETF (BATS:FLQL)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Atria Wealth Solutions Inc , Geneos Wealth Management Inc , Lockerman Financial Group Inc , International Assets Investment Management , Exchange Commission , Howard Capital Management Inc , Wealthcare Advisory Partners , Cap Multifactor Index , Free Report , Advisory Partners , Wealth Solutions , Capital Management , Wealth Management , Assets Investment Management , Lockerman Financial Group , Financial Group , Cap Equity , Visit Holdingschannel ,

Taysha Gene Therapies (NASDAQ:TSHA) Stock Rating Reaffirmed by Cantor Fitzgerald

Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “overweight” rating reissued by analysts at Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports. They currently have a $7.00 price target on the stock. Cantor Fitzgerald’s price target would suggest a potential upside of 191.67% from the company’s current price. A […] ....

Piper Sandler , Taysha Gene Therapies Inc , Dynamic Technology Lab Private Ltd , Maven Securities , Cantor Fitzgerald , Canaccord Genuity Group , Howard Capital Management Inc , Victory Capital Management Inc , Taysha Gene Therapies Company Profile , Capital Investment Advisors , Needham Company , Taysha Gene Therapies , Get Free Report , Genuity Group , Chardan Capital , Gene Therapies , Capital Management , Technology Lab Private Ltd , Investment Advisors , Taysha Gene Therapies Daily ,

Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 5.1%

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s stock price was up 5.1% during trading on Thursday . The stock traded as high as $2.86 and last traded at $2.86. Approximately 47,066 shares traded hands during trading, a decline of 98% from the average daily volume of 2,712,542 shares. The stock had previously closed […] ....

Capital Investment Advisors , Cantor Fitzgerald , Maven Securities , Canaccord Genuity Group , Dynamic Technology Lab Private Ltd , Howard Capital Management Inc , Victory Capital Management Inc , Needham Company , Taysha Gene Therapies Inc , Taysha Gene Therapies , Get Free Report , Genuity Group , Capital Management , Technology Lab Private Ltd , Investment Advisors , Gene Therapies , Taysha Gene Therapies Daily ,